MedCap AB (publ) reported earnings results for the third quarter and nine months ended September 30, 2021. For the third quarter, the company reported sales was SEK 202.3 million compared to SEK 175.4 million a year ago. Revenue was SEK 216 million compared to SEK 182.1 million a year ago. Net income was SEK 26.2 million compared to SEK 12.2 million a year ago. Basic earnings per share from continuing operations was SEK 1.7 compared to SEK 0.9 a year ago. Diluted earnings per share from continuing operations was SEK 1.7 compared to SEK 0.9 a year ago. Basic earnings per share was SEK 1.8 compared to SEK 0.8 a year ago. Diluted earnings per share was SEK 1.8 compared to SEK 0.8 a year ago. For the nine months, sales was SEK 658.4 million compared to SEK 590.4 million a year ago. Revenue was SEK 676.1 million compared to SEK 603.1 million a year ago. Net income was SEK 55.9 million compared to SEK 40.8 million a year ago. Basic earnings per share from continuing operations was SEK 3.8 compared to SEK 3 a year ago. Diluted earnings per share from continuing operations was SEK 3.8 compared to SEK 3 a year ago. Basic earnings per share was SEK 3.8 compared to SEK 2.9 a year ago. Diluted earnings per share was SEK 3.8 compared to SEK 2.9 a year ago.